Navigation Links
PrimeraDx Appoints David Heffelfinger as VP of Engineering and Systems Development
Date:12/1/2011

MANSFIELD, Mass., Dec. 1, 2011 /PRNewswire/ -- PrimeraDx today announced that David Heffelfinger has been appointed as Vice President of Engineering and Systems Development.

"It is an exciting time to join PrimeraDx.  The ICEPlex® System offers a glimpse into the future of molecular diagnostics, providing capabilities that are essential and timely," Commented Mr. Heffelfinger. 

"David brings to PrimeraDx extensive experience in the medical device industry and is a great addition to the executive team.  His knowledge and background in engineering and systems development, as well as his quality systems experience and six sigma training, are well aligned with the Company's strategy to provide next generation molecular diagnostics to the clinical laboratory market," said President and CEO Matthew McManus.

Mr. David Heffelfinger has held many Executive-level engineering positions within life science and medical device companies including Beckman Coulter, BD Biosciences, and Bio-Rad Laboratories as well as several startups and venture capital backed companies including Biometric Imaging, Alpha Innotech Corp, and Luminys Systems.  Dave was also a founder of his own company, Hyperspectra LLC.  He began his professional career at General Motors Research Laboratories in Warren, Michigan as an Applied Physicist.  He received his B.S. and M.S. in Physics from Wayne State University and an Executive MBA from Saint Mary's College in Moraga, California.  He holds 27 US and international patents in the fields of imaging, optics, bio-systems, and instrumentation.

About PrimeraDx

PrimeraDx is a molecular diagnostics company that has developed, and is commercializing, a novel, game-changing clinical platform which combines PCR with capillary electrophoresis.  The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed and quantitative, answers to the clinic.  The company is pursuing a two-pronged strategy to sell the system in an Open Platform Mode to clinical labs and to collaborate with pharmaceutical companies to develop high-value companion and enabling diagnostic products.  Users can easily design very complex multi-modal assays that test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes.  PrimeraDx's technology represents the next generation of quantitative PCR.  The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysia Technology Development Corporation.  The Company's website is: www.primeradx.com or www.multiplexpcr.com.

CONTACT: Andrew Bond, +1-508-618-2752, abond@primeradx.com


'/>"/>
SOURCE PrimeraDx
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA
2. Ultragenyx Appoints Tom Kassberg as Chief Business Officer and Announces Management Team
3. CVS Caremark Appoints Kevin Murphy President of Accordant Business
4. Valeant Pharmaceuticals Appoints Howard B. Schiller as Chief Financial Officer
5. Adeona Appoints Jeff Lucero Riley as Independent Chairman
6. Champions Oncology, Inc. Appoints Executive Vice President and Chief Financial Officer to Management Team and Corporate Office Relocation
7. InterMune Appoints Angus C. Russell to Board of Directors
8. Volcano Corporation Appoints Leslie V. Norwalk and Dr. Eric J. Topol to Board of Directors
9. Vanda Pharmaceuticals Appoints Chief Commercial Officer
10. Cardica Appoints Christopher Littel VP, Sales and Marketing
11. S1 Pharmaceuticals Appoints Robert Taylor Segraves, MD, PhD, and Robert Pyke, MD, PhD to Its Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb. 8, 2016 Velano Vascular, a medical ... hospitalized patients and their practitioners, announced today that the ... Velano will use the proceeds from this financing, an ... in January 2015, to support the development and commercialization ... pediatric populations. Philadelphia , ...
(Date:2/8/2016)... CARLSBAD, Calif. , Feb. 8, 2016  HemaFlo Therapeutics, ... Office (USPTO) has issued US Patent Number 9,119,880 covering the ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ... technology." --> Dale Peterson , PhD, HemaFlo,s ... such a powerful technology." --> Dale ...
(Date:2/8/2016)... , Feb. 8, 2016  Astellas Pharma Inc. President and ... promotion of James Robinson as president, Americas Operations, ... in North and South America , effective ... US, representing the commercial organization in the United ... Masao Yoshida , who is retiring in ...
Breaking Medicine Technology:
(Date:2/8/2016)... , ... February 08, 2016 , ... ... enrichment program serving the greater Venice, FL area, has initiated a fundraiser for ... a car accident just four days after Christmas. To support this beautiful child ...
(Date:2/8/2016)... ... February 08, 2016 , ... Remember the old saying ... , According to Perry A~, author of “Calcium Bentonite Clay” the health benefits of ... in balancing and detoxifying the body. , A former motivational speaker, Perry A~ has ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show where ... see the most incredible gardens and home improvement experts that attend this amazing show. ... - 700 14th St. Denver CO, is an exciting event that Performance Mobility has ...
(Date:2/8/2016)... KS (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com ... leader in Mole removal products. , Moles are derived from a cluster of melanin ... in all the wrong places and create a lifetime of embarrassment. Historically, mole ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now online ... AutismOne 2016 Conference, which is being held May 25-29 at the Loews Chicago O’Hare ... helpful interventions and causes of chronic illness in children. , Very recent articles have ...
Breaking Medicine News(10 mins):